This exploration compound was initially documented by Hoffman-La Roche in 2009. It’s one among many benzodiazepines inside the imidazobenzodiazepine subgroup believed to deliver nootropic Added benefits. This relatively little group of benzodiazepines is residence to quite a few long-Long lasting substances that act as prodrugs for other benzodiazepines. I-Iomazenil (AKA https://williamh666mha1.digitollblog.com/profile